Navigation Links
FASEB SRC announces conference registration open for: Signal Transduction in the Immune System
Date:2/4/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): Signal Transduction in the Immune System.

The 2013 FASEB Science Research Conference on Signal Transduction in the Immune System will be focusing on recent advances in our understanding of the molecular mechanisms underlying the immune response. In the recent years, investigations aimed at understanding the innate and adaptive immune responses have provided a wealth of new information on the mechanisms regulating leukocyte activation and function.

Insights into this area have come from a wide array of approaches including human and mouse genetics, biochemical studies, in vivo imaging, cell biological approaches, mathematical modeling, and RNA biology. The overall objectives of this conference will be to bring together researchers in each of these disciplines, and to foster a more rapid and effective integration of the new information. This conference will also aim at disseminating new advances rapidly and broadly, with the expected outcome to benefit our ability to modulate the immune system for combating disease.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB SRC announces conference registration open for: Biology of Cilia and Flagella
2. FASEB SRC announces conference registration open for: Arf and Rab Family G Proteins
3. FASEB SRC announces conference: Glucose transport -- Gateway for Metabolic Systems Biology
4. FASEB SRC announces conference: Mitochondrial Assembly & Dynamics in Health, Disease & Aging
5. FASEB SRC announces: Molecular Mechanisms & Physiological Consequences of Protein Aggregation
6. FASEB SRC announces conference registration open for: Neural Mechanisms in Cardiovascular Regulation
7. FASEB SRC announces conference: Matricellular Proteins in Development, Health, and Disease
8. FASEB SRC announces conference registration open for: Biology and Chemistry of Vision
9. FASEB SRC announces conference registration open for: Hematologic Malignancies
10. FASEB SRC announces conference registration open for: Mechanisms in Plant Development Conference
11. FASEB SRC announces conference registration open for: Ciliate Molecular Biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. ... the faculty of the University of North Carolina Kenan-Flagler Business School ... entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading ...
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology: